5 CDMO Stocks to Add to Your Watchlist

February 8, 2026

In the pharmaceutical world, a CDMO (contract development and manufacturing organization) is essentially the “powerhouse behind the brand.”

Instead of a pharmaceutical company building their own factories and labs – which costs a lot – they hire a CDMO to handle everything from the initial drug chemistry to the mass production of the final pills or injections.

Advantage India

The country has developed from the ‘Pharmacy of the World’ (focused on cheap generic medicines) into a global CDMO hub.

This is why the Indian market is currently focused on this sector.

• Cost efficiency and skilled talent
  India offers a significant cost advantage – often 30-50% lower than Western countries – without sacrificing technical expertise. The country has one of the largest numbers of US FDA-approved factories outside the United States.

• The ‘China Plus One’ strategy
  Global pharmaceutical giants are looking to diversify their supply chains to reduce dependence on China. India is the main beneficiary of this shift as companies look for stable, English-speaking and legally compliant alternatives for drug development.

• Government boosts

  The Indian government’s Production Linked Incentive (PLI) programs are pumping money into the sector to encourage the production of ‘active pharmaceutical ingredients’, the raw materials that make medicines work.

With the sector booming, here are five CDMO stocks to add to your watchlist.

This is not stock advice.